A citizen science project enlisted 30 community volunteers to hunt for surviving hemlock trees in the Shining Rock Wilderness ...

Visit this renowned eco-lodge in the Caribbean rainforest to explore lush trails, spot wildlife, and wake up to the calls of ...

South Dakota is a paradise for outdoor lovers, and one of the best ways to enjoy the state's natural beauty is at Custer State Park's oldest and largest lodge.

RUPERT — Summer camp registration at Merck Forest & Farmland Center officially opens on February 7 at 9 a.m. With programs designed for children ages 3 to 13, Merck Forest camps provide unforgettable ...

Robert F. Kennedy Jr., President Trump’s nominee to be health secretary, would have oversight power over the vaccine’s maker, Merck, if confirmed. By Christina Jewett and Sheryl Gay Stolberg ...

It is early winter when MacKenzie, an atmospheric scientist and director of Birmingham University Institute of Forest Research, leads me further into this small patch of woodland here in ...

Nottingham Forest survived a late scare to move level on points with Arsenal in second with a 3-2 win at the City Ground against Premier League strugglers Southampton. Only goal difference ...

Forest's victory was their 13th in the Premier League this season In a season where Nottingham Forest have defied expectations in the Premier League, manager Nuno Espirito Santo was again keen to ...

Even the multimillion-dollar makeover intended to transform Orchard Road into a lush green corridor that connects Singapore’s historical green spaces passes over this secondary forest ...

Exclusive-Kennedy Played Key Role in Vaccine Case Against Merck By Dan Levine and Mike Spector (Reuters) - Robert F. Kennedy Jr. played an instrumental role in organizing mass litigation against ...

Jan 18 (Reuters) - Robert F. Kennedy Jr. played an instrumental role in organizing mass litigation against drugmaker Merck over its Gardasil vaccine, a strategy that faces its first test in a Los ...

Merck stock (NYSE: MRK) lost about 10% in 2024, underperforming the broader S&P 500 index, which gained 23% for the year. Despite strong performances from other pharmaceutical giants like Eli ...